Type 2 & other diabetes

DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes

Cardiovasc DiabetolPublished Propensity score-matched case-control analysis within a cohort

Authors' conclusion

These findings suggest that biological aging, as estimated through existing epigenetic tools, is associated with mortality risk in individuals with T2D, independently of common risk factors and that increased DNAm-surrogates of inflammatory protein levels characterize deceased T2D patients. Replication in larger cohorts is needed to assess the potential of this approach to refine mortality risk in T2D.

Study context

Population
Patients with T2D from a cohort of 568 followed for 16.8 years, balanced for all risk factors after propensity score matchingPS-matched subgroup
Participants
50 patients
Comparison
Deceased vs survived T2D patients
  • Deceasedn = 23
  • Survivedn = 27reference
Outcome
Epigenetic age (DNAmPhenoAge)
Methodological detailspropensity score matching, nested in cohort of 568 T2D patients followed 16.8 years
  • Propensity score matching
  • Nested in cohort of 568 T2D patients followed 16.8 years

Main finding

As reported in the abstract

P = 0.012

DNA methylation (DNAm) PhenoAge association with mortality, independent of canonical risk factors: HR
1.16 (95% CI 1.05-1.28; p = 0.004)

Observational data: associations, not effects.

Further findings

Median

OutcomeDeceasedSurvivedP value
DunedinPoAm pace of agingAccelerated in deceased1.05 (IQR 1.02–1.11)1.02 (IQR 0.98–1.06)P = 0.012
DunedinPoAm pace of aging — DunedinPoAm association with mortality, independent of canonical risk factors: HR
3.65 (95% CI 1.43-9.35; p = 0.007)

DNAm-estimated inflammatory proteins and cell counts

Epigenetic predictors of CXCL10, CXCL11 and enRAGE, CRP methylation risk score and DNAm-based exhausted CD8 + T cell counts higher in deceased vs survived

Original publication

DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes. Cardiovasc Diabetol. Published 13 July 2024. doi:10.1186/s12933-024-02351-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.